Del Principe O’Brien Financial Advisors March 2021 Commentary: Biogen Inc
Del Principe O’Brien Financial Advisors commentary for the month ended March 2021, discussing their portfolio holdings and their recent investment in Biogen Inc (NASDAQ:BIIB). Q1 2021 hedge fund letters, conferences and more Dear Fellow Investors, “There's nothing particularly earth-shattering about what we try to do. We believe the market often misprices stocks due to neglect, emotion, misinterpretation or myopia, so our value-add comes from bottom-up stock selection. We're trying to buy at low prices relative to our current estimate of intrinsic value and we want to believe that intrinsic va...
Fairpointe Mid-Cap Composite 4Q20 Commentary
Fairpointe Mid-Cap Composite commentary for the fourth quarter ended December 31, 2021. Q4 2020 hedge fund letters, conferences and more We See Benefits from Continued Market RotationThe trends in market rotation that we discussed recently have continued and have been positive for our stocks. After several years of markets being dominated by growth, momentum, and passive investing, we have seen a reset back to fundamental value-based investing. The pandemic in 2020 resulted in disruption to growth in economies around the world. With the availability of vaccines, attractively valued companies t...